Joachim Herz graduated from Medical School at the University of Heidelberg, Germany, in 1983. He continued training as a resident in surgery in Germany and England until he joined the European Molecular Biology Laboratory in 1985. There, he received training in Molecular Biology and conducted research work that included the identification and cloning of a novel member of the LDL receptor gene family, the LDL receptor-related protein (LRP). In 1989 Dr. Herz joined the Department of Molecular Genetics where in 1998 he attained his current position of Professor. He is the holder of the Thomas O. Hicks Family Distinguished Chair in Alzheimer’s Disease Research and the Presbyterian Village North Foundation Distinguished Chair in Alzheimer's Disease Therapeutic Research.
Dr. Herz’s current research focuses on the the molecular mechanisms by which the members of the LDL receptor gene family function as signaling and endocytic receptors in the brain and in the vascular wall. Recent work from his laboratory have revealed therapeutically amenable mechanisms that can be exploited for the development of novel treatment approaches for Multiple Sclerosis and the prevention of late-onset Alzheimer's Disease.
- Medical School
- Heidelberg University (1983), Medicine
- Amyotrophic Lateral Sclerosis
- Frontotemporal Dementia
- Lipid Metabolism and Atherosclerosis
- Multiple Sclerosis
- Synaptic Physiology and Alzheimer's Disease
- How We Can Rebuild Trust in Science-And Why We Must.
- Boele-Woelki K, Francisco JS, Hahn U, Herz J Angew. Chem. Int. Ed. Engl. 2018 Jul
- Author Correction: Loss of the adaptor protein ShcA in endothelial cells protects against monocyte macrophage adhesion, LDL-oxydation, and atherosclerotic lesion formation.
- Abou-Jaoude A, Badiqué L, Mlih M, Awan S, Guo S, Lemle A, Abboud C, Foppolo S, Host L, Terrand J, Justiniano H, Herz J, Matz RL, Boucher P Sci Rep 2018 Jun 8 1 9577
- Low density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression.
- Hamlin AN, Chinnarasu S, Ding Y, Xian X, Herz J, Jaeschke A, Hui DY J. Biol. Chem. 2018 May
- Intracellular lipid metabolism impairs ß cell compensation during diet-induced obesity.
- Ye R, Gordillo R, Shao M, Onodera T, Chen Z, Chen S, Lin X, SoRelle JA, Li X, Tang M, Keller MP, Kuliawat R, Attie AD, Gupta RK, Holland WL, Beutler B, Herz J, Scherer PE J. Clin. Invest. 2018 Mar 128 3 1178-1189
- Loss of the adaptor protein ShcA in endothelial cells protects against monocyte macrophage adhesion, LDL-oxydation, and atherosclerotic lesion formation.
- Jaoude AA, Badiqué L, Mlih M, Awan S, Guo S, Lemle A, Abboud C, Foppolo S, Host L, Terrand J, Justiniano H, Herz J, Matz RL, Boucher P Sci Rep 2018 Mar 8 1 4501
- Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.
- Sacharidou A, Chambliss KL, Ulrich V, Salmon JE, Shen YM, Herz J, Hui DY, Terada LS, Shaul PW, Mineo C Blood 2018 Mar
- Lrp4/Wise regulates palatal rugae development through Turing-type reaction-diffusion mechanisms.
- Kawasaki M, Kawasaki K, Meguro F, Yamada A, Ishikawa R, Porntaveetus T, Blackburn J, Otsuka-Tanaka Y, Saito N, Ota MS, Sharpe PT, Kessler JA, Herz J, Cobourne MT, Maeda T, Ohazama A PLoS ONE 2018 13 9 e0204126
- Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF-RANKL signaling.
- Bartelt A, Behler-Janbeck F, Beil FT, Koehne T, Müller B, Schmidt T, Heine M, Ochs L, Yilmaz T, Dietrich M, Tuckermann JP, Amling M, Herz J, Schinke T, Heeren J, Niemeier A Bone Res 2018 6 4
- LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis.
- Xian X, Ding Y, Dieckmann M, Zhou L, Plattner F, Liu M, Parks JS, Hammer RE, Boucher P, Tsai S, Herz J Elife 2017 Nov 6
- Building a better blood-brain barrier.
- Lane-Donovan C, Herz J Elife 2017 Oct 6
Homologous Recombination for Gene Replacement in Mouse Cell Lines. In Methods in Cell Biology 43: Protein Expression in Animal Cells
Thomas E. Willnow and Joachim Herz (1994). San Diego, M. Roth, ed., Academic Press
Genetic Manipulation of Lipoprotein Receptors: Implications for Lipid Metabolism and Atherosclerosis. In Cardiovascular Disease 94: Cellular and Molecular Mechanisms, Prevention, Treatment
Thomas E. Willnow, Shun Ishibashi and Joachim Herz (1994). New York, L. Gallo, ed., Pienum Press
Gene Inactivation by Homologous Recombination-Animal Models of Plasma Lipoprotein Disorders, Chapter 8. In Concepts in Gene Therapy
Thomas E. Willnow and Joachim Herz (1997). Berlin, New York, Michael Strauss and John Barranger, eds., Walter de Gruyter
Physiology of the LDL Receptor-Related Protein: Functions in ApoE-Mediated Remnant Metabolism and Other Biological Processes, Chapter 18. In Lipoproteins in Health and Disease
Joachim Herz (1999). London, Betteridge, Illingworth, and Shepherd, eds., Edward and Arnold
ApoE Receptors in the Brain: Novel Signaling Pathways with Potential Relevance for Alzheimer's Disease. In Research and Perspectives in Alzheimer's Disease
Joachim Herz, Uwe Beffert, Thomas Hiesberger, Michael Gotthardt (2001). Berlin, Heidelberg, Hong Kong, London, Milan, Paris, Tokyo, Beyreuther, Christensen, Masters, eds.; Springer Verlag
Lipoprotein Receptors. In Encyclopedia of Molecular Medicine
Joachim Herz (). T. Creighton, ed; John Wiley and Sons
Lipoprotein Transport. In Transgenic Models in Pharmacology, Part 4. Cardiovascular System
Hans H. Bock, Petra May, Joachim Herz (2003). Berlin, Heidelberg, Hong Kong, London, Milan, Paris, Tokyo;, Stefan Offermanns, Lutz Hein, eds.; Springer Verlag,
Apolipoprotein E receptor 2 and very low density lipoprotein receptor: An overview.. In Fatemi, S.H. (ed), Reelin Glycoprotein, Structure, Biology and Roles in Health and Disease
Hans H. Bock and Joachim Herz (2008). New York, Springer
Conditional Animal Models for the Study of Lipid Metabolism and Lipid Disorders. In Handbook of Experimental Pharmacology
Hans H. Bock and Joachim Herz, Petra May (2007). Berlin, Heidelberg, Springer-Verlag
Honors & Awards
- Harrington Innovator Award
- NIH CMND Study Section
Standing Member (2019)
- Presbyterian Village North Foundation
Distinguished Chair in Alzheimer's Disease Therapeutic Research (2017)
- NIH Merit Award
- Alexander Humboldt Foundation, Germany
Advisory Board (2014)
- Pitt-Hopkins Research Foundation
Advisory Board (2014)
- Alexander-von-Humboldt Professorship
- Heinrich-Wieland Prized
International Lipid Research Award (2007)
- Thomas O. and Cinda Hicks Family Distinguished Chair
- Wolfgang Paul Award
Humboldt Foundation of Germany (2001)
- Lucille P. Markey Scholar
- Syntex Scholar